USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TARGEPEUTICS, INC.
Address:
475 W GOVERNOR RD
HERSHEY, PA 17033-1517
Phone:
(717) 520-1578
URL:
N/A
EIN:
232919015
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,785.00 2

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Lynn W. Maines
Abstract:
N/a

TAS::75 0849::TAS TOPIC 255 DEVELOPMENT OF GB13 AS A NOVEL GLIOBLASTOMA THERAPY

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$199,785.00
Agency:
HHS
Principal Investigator:
Stephen Abramson – 717-533-7772
Abstract:
This Phase I SBIR contract is to (1) produce multiple lots of GB13 to establish the quality and reproducibility of the manufacturing process, (2) characterize biochemical properties of GB13, including affinity to target cells, (3) qualify a live cell-basedbioassay with multiple product lots, (4)… More